|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 65.49 USD | +0.37% |
|
+3.18% | -15.79% |
| 12-05 | Health Rounds: Shingles vaccine reduces risk of death from dementia, study finds | RE |
| 12-04 | Dexcom Launches New Education Offering, Dexcom Academy | CI |
| Capitalization | 25.54B 21.96B 20.57B 19.17B 35.41B 2,299B 38.52B 241B 92.89B 1,086B 95.86B 93.82B 3,970B | P/E ratio 2025 * |
31.7x | P/E ratio 2026 * | 27.1x |
|---|---|---|---|---|---|
| Enterprise value | 25.69B 22.09B 20.69B 19.29B 35.62B 2,312B 38.74B 242B 93.45B 1,092B 96.44B 94.38B 3,993B | EV / Sales 2025 * |
5.53x | EV / Sales 2026 * | 4.77x |
| Free-Float |
95.22% | Yield 2025 * |
-
| Yield 2026 * | - |
Last Transcript: DexCom, Inc.
| 1 day | +0.37% | ||
| 1 week | +3.18% | ||
| Current month | +3.18% | ||
| 1 month | +12.87% | ||
| 3 months | -18.66% | ||
| 6 months | -24.44% | ||
| Current year | -15.79% |
| 1 week | 62.32 |  | 66.75 |
| 1 month | 54.2 | | 66.75 |
| Current year | 54.11 | | 93.25 |
| 1 year | 54.11 | | 93.25 |
| 3 years | 54.11 | | 142 |
| 5 years | 54.11 | | 164.86 |
| 10 years | 10.66 | | 164.86 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jacob Leach
CEO | Chief Executive Officer | 46 | 13/09/2025 |
Jereme Sylvain
DFI | Director of Finance/CFO | 45 | 18/03/2021 |
| Chief Tech/Sci/R&D Officer | 48 | 30/09/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Nick Augustinos
BRD | Director/Board Member | 66 | 19/11/2009 |
Steven Altman
BRD | Director/Board Member | 63 | 06/11/2013 |
Mark Foletta
CHM | Chairman | 65 | 13/09/2025 |
| Name | Weight | AuM | Varia. Jan 1. | Investor |
|---|---|---|---|---|
 | 1.46% | 26 M€ | +11.73% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.37% | +3.18% | -15.74% | -43.94% | 25.54B | |
| -0.26% | -2.96% | +8.20% | +20.43% | 217B | |
| -0.62% | -3.77% | +20.65% | +31.50% | 130B | |
| +0.60% | -7.93% | +39.54% | +100.60% | 65.89B | |
| +0.10% | -0.03% | -11.84% | -20.64% | 55.36B | |
| +0.25% | +1.92% | +17.82% | +76.38% | 52.03B | |
| +0.87% | -1.13% | +21.95% | +43.42% | 25.84B | |
| -0.33% | +2.89% | +18.63% | -34.55% | 24.14B | |
| -2.23% | -2.91% | -23.08% | +19.35% | 22.48B | |
| -3.62% | -6.94% | +14.70% | +1.51% | 21.42B | |
| Average | -0.49% | -1.77% | +9.08% | +19.41% | 64.02B | |
| Weighted average by Cap. | -0.29% | -2.58% | +12.11% | +27.54% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 4.64B 3.99B 3.74B 3.49B 6.44B 418B 7B 43.75B 16.89B 197B 17.43B 17.06B 722B | 5.23B 4.5B 4.21B 3.93B 7.25B 471B 7.89B 49.29B 19.03B 222B 19.64B 19.22B 813B |
| Net income | 831M 715M 669M 624M 1.15B 74.81B 1.25B 7.83B 3.02B 35.33B 3.12B 3.05B 129B | 989M 850M 797M 743M 1.37B 89.04B 1.49B 9.32B 3.6B 42.05B 3.71B 3.63B 154B |
| Net Debt | 153M 131M 123M 114M 211M 13.73B 230M 1.44B 555M 6.48B 572M 560M 23.7B | -587M -504M -473M -440M -814M -52.82B -885M -5.53B -2.13B -24.95B -2.2B -2.16B -91.21B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 05/12/25 | 65.49 $ | +0.37% | 3,854,687 |
| 04/12/25 | 65.25 $ | +0.62% | 3,484,310 |
| 03/12/25 | 64.85 $ | +0.62% | 3,710,786 |
| 02/12/25 | 64.45 $ | +1.46% | 4,799,533 |
| 01/12/25 | 63.52 $ | +0.08% | 5,209,243 |
Delayed Quote Nasdaq, December 05, 2025 at 09:00 pm
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- DXCM Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition